OmniAb (OABI) Change in Intangibles (2025)
OmniAb's (OABI) quarterly Change in Intangibles came in at $3.0 million in Q2 2025.
OmniAb (OABI) Change in Intangibles (2025) Analysis & Trends
OmniAb (OABI) has 1 years of Change in Intangibles data on file, last reported at $3.0 million in Q2 2025.
- On a quarterly basis, Change in Intangibles changed N/A year-over-year to $3.0 million in Q2 2025; TTM through Dec 2025 was $3.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.0 million, changed N/A from the prior year.
- Change in Intangibles for Q2 2025 stood at $3.0 million.
- Over the last five years, Change in Intangibles for OABI reached as high as $3.0 million in Q2 2025 and fell as low as $3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | - |
| 10 | OmniAb | 259.70 Mn | 210.62 Mn | 14.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |